Lanean...
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
DNA vaccines present one of the most cost-effective platforms to develop global vaccines, which have been tested for nearly three decades in preclinical and clinical settings with some success in the clinic. However, one of the major challenges for the development of DNA vaccines is their poor immun...
Gorde:
| Argitaratua izan da: | Vaccines (Basel) |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630607/ https://ncbi.nlm.nih.gov/pubmed/31052178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines7020038 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|